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PALLADIUM CATALYZED ANNULATION OF 
INTERNAL ALKYNES 
The present invention was made with the support of the 
National Institutes of Health under Grant No. GM40036. 
The US. Government has certain rights in the invention. 
BACKGROUND OF THE INVENTION 
The transition metal-mediated cycloaddition reactions of 
alkynes are of great current interest. See, for example, N. E. 
Schore, Chem. Rev., 88, 1081 (1988). While palladium is 
among the most widely studied metals for such processes, 
multiple alkyne insertions, or insertion and subsequent 
cyclization back on to a preexisting aromatic ring usually 
predominates. For example, see P. M. Maitlis, J. Organomet. 
Chem, 200, 1616 (1980). However, a number of groups 
have recently reported the successful synthesis of fused 
heterocyclic ring systems employing transition metal cataly~ 
ses. For example, Larock et al., J. Amen Chem. Soc, 113, 
6689 (1991) have reported the synthesis of various indoles 
via the palladium-catalyzed heteroannulation of internal 
alkynes (eq 1): 
NI-IR1 (1) 
+ Rzc : CR3 cat. Pd(O) 5 
_ base 
I 
R1 
I \ 
N R2 
wherein R1 is H, CH3, Ac or Ts, and R2 and R3 are phenyl 
or alkyl, among others. Synthetic routes to 2-mono-substi 
tuted benzofurans via heteroannulation of terminal alkynes 
have been reported by Castro et al., J. Org. Chem., 31, 4071 
(1966); Arcadi et al., Synthesis, 749 (1989); and Kundo et 
al., J. Chem. Soc., Chem. Commun., 41 (1992). Castro et a1. 
did not utilize a palladium catalyst and required the cuprous 
form of the acetylide (eq. 2). Castro et al. and Kundo et al. 
also utilized palladium with a copper cocatalyst (eq. 3). 
Br (2) 
R1 + CuC 5 CR1 —W ‘dine/‘3MP 
OH 
R1 \ R2 + CuBr 
O 
(R1 = halo; R2 = phenyl, propyl). 
PdClz, C111 (3) 
I DMF > 
+ HC E CR or 
on % Pd(OAC2)(PPh3)2, DMF 
O 
(R = alkyl, hydroxyalkyl). 
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A single example of Pd-catalyzed carboannulation to 
yield a 1,1,2,3-tetrasubstituted indene has been reported by 
R. Larock in Pure & Appl. Chem., 62, 653 (1990). 
Therefore, a continuing need exists for effective methods 
to prepare multi-ring aromatic and heteroaromatic ring sys 
tems from relatively simple precursors. 
SUMMARY OF THE INVENTION 
The present invention provides an ef?cient, one-step 
method for preparing fused-ring aromatic compounds, com 
prising reacting (a) an iodoaryl compound of formula (1): 
Y (1) 
(Ar) 
I 
wherein Y is OH or C(R3)(R4)X, wherein R3 and R4 are 
individually H, phenyl or (C1—C4)alkyl; X is OH, N02, 
COZR5 NH2 or NHC(O)R5, wherein R5 is aryl or 
(C1—C4)alkyl; Ar is a substituted aryl or unsubstituted aryl 
moiety, and Y and I are positioned adjacent to each other on 
said moiety; with (b) an internal alkyne of the formula 
RICECR2 wherein R1 and R2 are individually 
(C1—C6)alkyl, aryl, CO2R5, CHO, Si(R3)3, 1-methyl(vinyl) 
or hydroxy(C1—C6)alkyl; in the presence of effective amount 
of a Pd catalyst, 21 base and a chloride ion source, in an 
organic solvent, to yield a compound of the formula (2): 
—C(R3)(R4)NH— or —-CH(NO2)—; and R1_RS are as 
de?ned above. 
As noted above, Z andI are on adjacent atoms of Ar, i.e., 
they are ortho in the sense that they are 1,2; 2,3; 3,4, etc. on 
the ring(s). 
A preferred embodiment of formula (1) is a substituted or 
unsubstituted iodobenzene of the formula (3): 
R6 (3) 
R7 
wherein Y is as de?ned above, and R6 and R7 are individu 
ally (C1—C4)alkyl, chloro, bromo, hydroxy, phenyl, 
(cl_c4)alkoxy’ (C1“C4)a1ky1(C=0), 
(C1-C4)alkoxycarbonyl or together are benzo or methylene 
dioxy; which, when employed in the present method, yields 
a compound of the formula (4): 
R5 (4) 
Z 
/ R1 
R7 R2 
wherein Z, R1, R2, R6 and R7 are as de?ned above. 
Thus, the present invention provides a facile route to a 
number of aromatic heterocycles and carbocycles from 
5,596,100 
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readily available iodobenzenes or iodonaphthalenes, which 
proceeds in the absence of copper salts or copper catalysts 
employed by the art with terminal alkynes to form 2-sub 
stituted benzofurans. Compounds of formula 2 include l-ni 
tro or l-carboalkoxy-indenes (Z=CH(CO2R5) or CH(NO2); 
7,8-disubstituted-1,2-dihydroisoquinolines 
(Z=C(R3)(R4)N(C(O)R5)); 2,3-disubstituted benzofurans 
(Z=O); and 3,4-disubstituted benzopyrans 
(Z:C(R3)(R4)O). 
These classes of aromatic heterocycles encompass well 
known dyes, pharmaceuticals and biocidal compounds such 
as antimicrobial agents and herbicides, as well as interme 
diates for the preparation thereof. 
Preferably, R.3 and R4 are both H or both CH3, R5 is CH3 
or CH2CH3, R6 and R7 are H, (C1—C4)alkyl or acetyl, and R1 
and R2 are individually (C1—C4)alkyl, phenyl, 
CO2(C1—C4)alkyl, CHO or Si((C1—C4)alkyl)3. As used 
herein, the term “alkyl” includes straight chain alkyl, 
branched alkyl, cycloalkyl, or (cycloalkyl)alkyl, i.e., methyl, 
ethyl, isopropyl, t-butyl, cyclopropyl, cyclohexyl, cyclopro 
pylmethyl, and the like. The term “hydroxyalkyl” indicates 
that the hydroxy group can be at any carbon of the alkyl 
group. 
DETAILED DESCRIPTION OF THE 
INVENTION 
A wide variety of substituted and unsubstituted aryl 
iodides (ArI) can be employed as starting materials in the 
present process, and the Ar (“aryl”) or R2- or Rs-aryl 
moieties in compound (2) can likewise be substituted or 
unsubstituted. Preferably, Ar or aryl is a C6—C1o aryl moiety, 
such as phenyl, naphthyl, 2- or 3- thienyl, 2- or 3- furyl, 2-, 
3- or 4-pyridy1 and the like. A wide variety of 1—3 non-iodo 
substituents can be present on the Ar or aryl group, including 
Ph, Br, Cl, F, formyl, OH, amino, nitro, —CH(OCH3)2, 
—CH(OEt)2, —CO2R5, —CN, (C1-C4)a1kyl, 
(C1—C4)alkoxy, phenoxy, methylene-dioxy, 
(C1—C4)alkoxycarbonyl, (C1-C4)alkylcarbonyl, 
hydroxy(C1—C4)alky1, (R3)(R4)N and (R5)S—, wherein R3, 
R4 and R5 is as de?ned above. Other representative Ar 
substituents are given in Blaser et al. (U.S. Pat. No. 4,335, 
054), the disclosure of which is incorporated by reference 
herein, at Col. 2, line 19 to C01. 3, line 3. The term “aryl” 
also includes ar(C1—C4)alkyl, e.g., phenethyl or benzyl. 
Preferably, Ar or aryl is phenyl (Ph) or is phenyl substituted 
with (C1—C4)alkoxy, acetyl, 3,4-methylene-dioxy, 3,4,5 
(tris)-methoxy, hydroxymethyl and the like. 
In fact, the upper limits on the molecular weights of the 
compound of formula (1) are controlled only by physical or 
practical considerations, such as the solubility of the starting 
materials, the cost of the starting materials, the reaction 
conditions and the like. 
The compound which is the source of the catalyst is 
generally employed in an amount of about 0.001-20 mol-%, 
preferably 0.1-10 mol-%, based on the compound of for 
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mula 1. Useful Pd(0) catalysts include, for example, bis~ 
(dibenzylideneacetone)palladium(O), bis(isonitrile)palla 
dium(0), bis(cyclohexylisonitrile)palladium(0), bis 
(isopropylisonitrile)palladium(0), bis-(tert.-butylisonitri1e) 
palladium(O), bis-(p-tolylisonitrile)palladium(0), and bis-(p 
methoxyphenylisonitrile)palladium(0). Other Pd-containing 
compounds, e.g., Pd(II) compounds, can also be used in the 
present method. These include PdCl2, palladium(II) car 
boxylate salts, such as Pd(OAc)2, PdBr2, Pd(CN)2, 
Pd(NO3)2, PdSO4 and the like. Other Pd catalysts which can 
be used in the present method include those disclosed in 
Blaser et al. (US. Pat. No. 4,335,054) at Col. 6, line 5 to C01. 
7, line 3. 
Bases used in the present process can be inorganic or 
organic bases, which are adequately soluble in the reaction 
medium. Representative bases are disclosed at Col. 7, lines 
8—65 of the Blaser et al. patent. Inorganic bases for use in the 
present process include Na2CO3, KHCO3, Li2CO3, KZCO3 
and NaHCO3. Useful organic bases include sodium or 
potassium acetate, or trialkylamines, such as triethylamine 
and diisopropyl(ethyl)arnine. Preferably, organic bases are 
used. The preferred mole ratio of the base to the compound 
of formula 1 is about 2—3:1. 
A source of halide, such as chloride ion, is also preferably 
used in the present process, in an amount effective to 
promote the reaction and increase the yield. Organic chlo 
ride sources, such as tetra(alkyl)ammonium chlorides, 
wherein the alkyls can each be about (C2—C12)alkyl, are 
preferred, i.e., (n-Bu)4NCl. Alkali metal halides such as MX, 
wherein M is Li, Na, or K and X is Cl, Br or I, can also be 
used. Preferred in the present method are LiCl or tetra-n 
butylammonium chloride (n-Bu4NCl). The halide source is 
preferably used in an equimolar amount or in only a slight 
excess over the compound of formula 1, (l.l—l.5 equiva 
lents). 
In carrying out the synthesis of the compound of formula 
(2), the aryl iodide (1)1 is preferably combined with an 
excess of the disubstituted acetylene, e.g., preferably in a 
mole ratio of about 1:l.l—l0, in a suitable organic solvent. 
The reaction mixture is preferably stirred at about 50°—l50° 
C. for about 8—48 hr under an inert atmosphere. The crude 
product is extracted, i.e., into ethyl acetate and can be 
puri?ed by chromatography. 
Useful organic solvents include tetrahydrofuran (TI-IF), 
ethers, glycol ethers, dimethylsulfoxide, dimethylforma 
mide (DMF), acetonitrile, acetarnide, dimethylacetarnide, 
and hexamethylphosphorarnide, and aqueous combinations 
of these solvents. 
In some cases, addition of catalytic amounts of triph 
enylphosphine (PPh3) was found to improve the yield of 
product. 
A summary of the examples is presented on Table 1, 
below. 
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The experiments initially employed o-iodobenzylamine 
(entry 23), but annulation with this substrate proved sluggish 
and even at elevated temperatures only low yields of 1,2 
dihydroisoquinolines could be obtained. By employing the 
corresponding acetamide, instead of the free amine, 
improved yields were obtained (entries 1-6). Alkynes con 
taining aryl or carbonyl-containing groups gave the best 
results, and proved highly regioselective. 
Heteroannulation using o~iodopheno1 proved more dif? 
cult than analogous reactions of o-iodoaniline (entries 
7-13). At the higher temperatures required, reduced regi 
oselectivity is sometimes observed. While the heteroannu 
lation of 4,4-dimethyl-2-pentyne by o-iodophenol (entry 7) 
at 100° C. gave exclusively 2-t-butyl-3-methylbenzofuran,, 
the analogous, higher-yielding reaction of o-iodophenol run 
at 135° C. gave a 9:1 mixture of regioisomers (entry 8). The 
annulation of 2-methyl-1-hexen-3-yne (entry 9) and ethyl 
phenylpropiolate (entry 10) at 1350 C. also aiforded mix 
tures of regioisomers. Hindered silylalkynes give high yields 
of the corresponding 2-silylbenzofurans (entries 12 and 13). 
This process complements the copper/palladium-catalyzed 
coupling of o-iodophenol with terminal alkynes, which 
a?‘ords 2-substituted benzofuran as discussed above, 
because the silyl-substituted benzofurans are readily desily 
lated to 3-substituted benzofurans by ?uoride salts (eq. 2). 
0 Si(i-Pr)3 xnznzo (2) 
n-Bu4NCl 
MeCN 
Ac Me 60° c, 6.5 h 
0 H 
Ac Me 
Although alcohols are not particularly good nucleophiles in 
palladium-based methodology, o-iodobenzylic alcohols 
have proven e?'ective for the synthesis of benzopyrans 
(entries 16-19), best results again being obtained using 
hindered alkyl, aryl or carbonyl-containing alkynes. 
Aryl halides bearing an ethoxylcarbonyl group as a car 
banion-stabilizing group, such as 2-iodo-phenylacetie acid 
ethyl ester (entry 20), or 1-nitromethyl-2-iodobenzene 
(entries 21-22) can also be employed to yield lsubstituted 
indenes. 
Although the regiochemistry of every product has not 
been rigorously established, it appears that generally the aryl 
group is added to the less hindered end of the alkyne and the 
palladium moiety to the more hindered end. 
The invention will be further described by reference to the 
following detailed examples. 
EXAMPLE 1 
General Procedure for the Palladium-Catalyzed 
Heteroannulation of Alkynes 
Palladium acetate (0.0025 mmol), LiCl (0.50 mmol) or 
n-Bu4Cl (Lancaster, 0.50 mmol), the appropriate base 
(0.5-2.50 mmol), the aryl iodide (0.50—1.5 mmol), the 
alkyne (0.5-2.5 mmol), the solvent (10 or 20 ml) and, where 
indicated, PPh3 (0.025 mmol) were added to a 2 or 4 dram 
vial equipped with a stirring bar and heated at the appro 
priate temperature for the necessary period of time. The 
reaction mixture was diluted with ether, washed succes 
sively with saturated NH4Cl and water, dried over anhy 
drous MgSO4, and concentrated. The products were puri?ed 
20 
35 
40 
50 
55 
60 
16 
by ?ash column chromatography. The following compounds 
were prepared using this general procedure. 
A. Ethyl 2-Acety1-l,2-dihydro-3-phenylisoquinoline-4 
carboxylate (entries 1 and 2): 1H NMR (CDCl3) 8 0.92 
(t, J=7.2 Hz, 3H, CH3, 1.54 (s, 3H, CH3), 4.04 (q,J=7.2 
Hz, 2H, CH2), 5.05 (s, 2H, CH2), 7.26-7.60 (m, 8H, 
aryl), 7.76 (d, J=6.3 Hz, 1H, aryl); 13C NMR (CDCl3) 
8 18.5, 24.5, 40.2, 61.1, 122.2, 123.4, 125.9, 127.7, 
128.1, 128.5, 128.7, 129.3, 129.5, 131.9, 140.7, 167.4, 
171.2; IR (CDCl3) 1717 (C=O) cm_1; HRMS Calcd 
for C2OH19NO3: 321.1365. Found: 321.1364. 
B. 2-Acetyl-1,2-dihydro-3,4-diphenylisoquinoline (entry 
3): 1H NMR (CDC13) 8 1.56 (s, 3H, CH3), 5.17 (s, 2H, 
CH2), 7.09-7.37 (m, 14H, aryl); 13C NMR (CDC13) 8 
24.0, 46.0, 118.1, 125.0, 125.2, 126.9, 127.2, 127.5, 
127.7, 128.1, 129.6, 129.9, 130.7, 132.8, 133.6, 136.3, 
136.5, 137.2, 170.1; IR (CDCl3) 1659 (C=O) cm'l; 
HRMS Calcd for C23H19NO: 325.1467. Found: 
325.1458. 
C. 2-Aeetyl-1,2-dihydro-4-methy1-3-phenylisoquinoline 
(entries 4 and 5): 1H NMR (CDCl3) 8 1.47 (s, 3H, 
CH3), 2.24 (s, 3H, CH3), 5.00 (s, 2H, CH2), 7.2—7.45 
(m, 9H, aryl); 13C NMR (CDCl3) 8 15.6, 24.1, 45.7, 
122.6, 123.6, 123.7, 124.8, 127.3, 127.9, 128.2, 129.9, 
133.7, 136.1, 137.6, 137.8, 171.0; IR (CDCl3) 1732 
(C=O)cm_1; HRMS Calcd for CISHWNO: 263.1311. 
Found: 263.1310. 
D. 2-Acety1-, 1 ,2-dihydro-4-formyl-3-phenylisoquinoline 
(entry 6): 1H NMR (CDCl3) 8 1.84 (s, 3H, CH3), 5.12 
(s, 2H, CH2), 7.45 (m, 4H, aryl), 7.85 (m, 4 H, aryl), 
8.51 (d, J=7.8 Hz, 1H, aryl), 9.75 (s, 1H, CHO); 13C 
NMR (CDCl3) 8 24.9, 48.9, 123.4, 124.9, 125.8, 127.7, 
128.0, 128.1, 128.9, 131.3, 131.7, 134.0, 140.1, 155.9, 
171.1, 190.8; IR (CDCl3) 1736 (C=O) cm_1; HRMS 
Calcd for C18H15NO2: 277.1103. Found: 277.1101. 
E. 2-t-Butyl-3-methy1benzofuran (entries 7 and 8): 1H 
NMR (CDCl3) 8 1.49 (s, 9H, CH3), 2.35 (s, 3H, CH3), 
7.25 (m, 2H, aryl), 7.40 (In, 2H, aryl); 13C NMR 
(CDCl3) 8 9.0, 29.5, 34.3, 107.3, 110.3, 118.4, 121.7, 
123.0, 131.5, 152.8, 159.7; IR (neat) 2961, 1477 cm_1; 
HRMS Calcd for C13H16O: 188.1204. Found: 
188.1201. 
F. 3-Ethyl-2-isopropenylbenzofuran and 2-ethyl-3—isopro 
penylbenzofuran (9:1 mixture) (entry 9): 1H NMR 
(CDCl3) 8 1.21 (t, J=7.5 Hz, 3H, CH3), 2.14 (S, 3H, 
CH3), 2.77 (q, J=7.5 Hz, 2H, CH2), 5.15 (s, 1H, vinyl), 
5.44 (s, 1H, vinyl), 7.15 (m, 2H, aryl), 7.33 (d, J=8.1 
Hz, 1H, aryl), 7.43 (d, J:8.1 Hz, 1 H, aryl); 13C NMR 
(CDCl3) 8 14.6, 176,210, 110.8, 115.0, 118.0, 119.3, 
122.0, 124.2, 130.0, 134.6, 151.4, 153.4; IR (neat) 
2964, 1287 cm_1; HRMS Calcd for CIBHMO: 
186.1045. Found: 186.1044. 
G. Ethyl 2-phenylbenzofuran-3-carboxylate and ethyl 
3—phenylbenzofuran-2-carboxylate (3:2 mixture) (entry 
10): 1H NMR (CDCl3) 8 1.34 (t, J=7.5 Hz, 6H, CH3), 
4.34 (q, J=7.5 Hz, 4H, CH2), 7.28 (m, 4H, aryl), 7.42 
(m, 10H, aryl), 7.98 (m, 4H, aryl); 13C NMR (CDC13) 
814.2,14.3,14.3, 21.0, 60.3, 60.6,111.0,122.6,123.9, 
125.1, 127.1, 128.0, 129.5, 129.6, 130.1, 153.7, 160.8, 
163.9, 171.1; IR (neat) 1716 (C=O) cm_1; HRMS 
Calcd for C17H14O: 266.0943. Found: 266.0944. 
H. Diethyl benzofuran-2,3-dicarboxylate (entry 11): 1H 
NMR (CDCl3) 8 1.45 (t, J=7.2 Hz, 6H, CH3). 4.48 (q, 
J=7.2 Hz, 4H, CH2), 7.38 (t, J=7.38 (t, J=7.8 HZ, 1H, 
aryl), 7.49 (t, J=7.2 Hz, 1H, aryl), 7.59 (d, J=7.8 Hz, 
1H, aryl), 7.92 (d, J=7.8 HZ, 1H, aryl); 13C NMR 
(CDC13) 8 14.2, 14.3, 61.6, 62.2, 112.2, 118.2, 122.7, 
124.6, 125.4, 127.9, 145.6, 154.0, 158.8, 162.5; IR 
(neat) 1726 (C=O) cm“; HRMS Calcd for C14H14O5: 
262.0841. Found: 262.0843. 
5,596,100 
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1. 3-Methyl-2-(triisopropylsilyl)benzofuran (entry 12): 1H 
NMR (CDCl3) 8 1.13 (d, J=7.5 Hz, 18H, CH3), 1.50 
(septet, J=7.5 Hz, 3H, CH), 2.33 (s, 3H, CH3), 
7.15-7.30 (m, 2H, aryl), 7.44 (d, J=7.8 Hz, 1H, aryl), 
7.51 (d, J=6.9 Hz, 1H, m1); 13(3 NMR(CDC13) 8 8.4, 
11.6, 18.6, 111.0, 119.0, 121.5, 123.3, 126.3, 129.9, 
155.1, 157.6; IR (CHCl3) 2944, 1461 cm“; HRMS 
Calcd for C18H28OSi: 288.1909. Found: 288.1908. 
J. 3-Phenyl-2-(triisopropylsilyl)benzofuran (entry 13): 1H 
NMR (CDCl3) 8 1.02 (d, J=7.5 Hz, 18H, CH3), 1.29 
(septet, J=7.5 Hz, 3H, CH), 7.10-7.60 (m, 9H, aryl); 
13C NMR (CDCIB) 8 11.7, 18.7, 111.1, 120.0, 122.1, 
124.3, 127.6, 128.0, 129.5, 130.0, 133.3, 133.7, 156.1, 
157.6; IR (CHCl3) 2945, 1463 cm_1; HRMS Calcd for 
C23H30OSi: 350.2066. Found: 350.2093. 
K. 5-Acetyl-2-t-butyl-3-methylbenzofuran (entry 14): 1H 
NMR (CDCl3) 8 1.37 (s, 9H, CH3), 2.27 (s, 3H, CH3), 
2.59 (s, 3H, CH3), 7.31 (d, J=8.4 Hz, 1H aryl), 7.79 (dd, 
J=1.8, 8.4 Hz, 1H, aryl), 7.99 (d, J=1.8 Hz, 1H, aryl); 
13C NMR (CDCl3) 8 8.9, 26.7, 29.4, 34.4, 108.1, 110.2, 
119.7, 124.2, 131.7, 131.8, 155.6, 161.5, 197.9; IR 
(neat) 1688 (C=O) cm_1; HRMS Calcd for C15H18O2: 
230.1307. Found: 230.1302. 
L. 5-Acetyl-3-methyl-2-(triisopropylsilyl)benzofuran (entry 15): H NMR (CDCl3) 8 1.13 (d, J=7.5 Hz, 18H, 
CH3), 1.51 (septet, J=7.5 Hz, 3H, CH), 2.37 (s, 3H, 
CH3), 2.67 (s, 3H, CH3), 7.45 (d, J=8.7 Hz, 1H, aryl), 
7.93 (dd, J =l.8, 8.7 Hz, 1H, aryl), 8.17 (d, J=1.8 Hz, 
1H, aryl); 13C NMR (CDCl3) 8 9.3, 11.5, 18.5, 26.7, 
110.8, 120.5, 124.8, 127.0, 130.2, 131.7, 157.5, 160.3, 
197.7; IR (CHCl3) 1675 (C=O) cm“; HRMS Calcd 
for CZOHBOOZSi: 330.2051. Found: 330.2012. 
M. 3-t-Butyl-l,l-dimethyl-4-methylisochromene (entry 
16): 1H NMR (CDCl3) 8 1.27 (s, 9H, CH3), 1.52 (s, 6H, 
CH3), 2.12 (s, 3H, CH3), 7.0-7.3 (m, 4H, aryl); 13C 
NMR (CDCl3) 8 13.7, 26.1, 29.0, 36.3, 75.5, 104.0, 
120.8, 121.5, 125.6, 127.0, 134.2, 136.8, 155.7; IR 
(CHCl3) 2921, 1621 cm“; HRMS Calcd for C16H22O: 
230.1671. Found: 230.1674. 
N. 1,l-Dimethyl-3,4-diphenylisochromene (entry 17): 1H 
NMR (CDCIB) 8 1.79 (s, 6H, CH3), 6.88 (d, J=7.5 Hz, 
1H, aryl), 7.0—7.4 (m, 13H, aryl); 13C NMR (CDCl3) 8 
27.1, 77.6, 115.6, 122.1, 123.5, 126.8, 127.1, 127.4, 
127.5, 127.7, 128.5, 128.7, 131.6, 131.9, 135.9, 136.3, 
137.0, 148.1; IR (CHCl3) 2918, 1616 cm_1; HRMS 
Calcd for C23H20O: 312.1514. Found: 312.1523. 
0. Ethyl l,l-dimethyl-3-phenylisochromene—4-carboxy— 
late (entry 18): 1H NMR (CDC13) 8 0.89 (t, J=7.2 Hz, 
3H, CH3), 1.74 (s, 6H, CH3), 4.00 (q, J=7.2 Hz, 2H, 
CH2), 7.1—7.6 (m, 8H, aryl), 7.9 (dd, J:1.2, 7.5 Hz, 1H, 
aryl); 13C NMR (CDCl3) 8 13.5, 27.0, 60.4, 79.5, 
108.2, 122.2, 122.8, 127.1, 127.5, 127.7, 127.9, 128.4, 
129.6, 134.9, 135.6, 157.4, 168.0; IR (CHCl3) 2928, 
1708 cm“; HRMS Calcd for CZOHZOO3: 308.1412. 
Found: 308.1419. 
P. l , l-Dimethyl-3-(1-hydroxy- l -methylethyl)-4-phenyl 
isochromene (entry 19): 1H NMR (CDCl3) 8 1.28 (s, 
6H, CH3). 1.70 (s, 6H, CH3), 2.22 (s, 1H, OH), 6.50 (d, 
J=7.5 Hz, 1H, aryl), 7.0—7.6 (m, 8H, aryl); 13C NMR 
(CDCl3) 8 26.9, 29.3, 72.9, 112.3, 121.8, 123.6, 126.7, 
127.1,127.3, 128.5, 131.3, 132.4, 135.7, 136.9, 153.1; 
IR (CHCl3) 3500, 2920 cm“; HRMS Calcd for 
C2oH22O2: 294.1620. Found: 294.1625. 
All publications, patents and patent documents are incor 
porated by reference herein, as though individually incor 
porated by reference. The invention has been described with 
reference to various speci?c and preferred embodiments and 
techniques. However, it should be understood that many 
variations and modi?cations may be made while remaining 
within the spirit and scope of the invention. 
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What is claimed is: 
l. A process of preparing a compound of formula (2): 
z (2) 
wherein R1 and R2 are individually (C1—C6)alkyl, 
(C6—C1o)aryl, COZRS, CHO, Si(R3)3, l-methyl(vinyl) or 
hydroxy(C1—C6)alky1; Z is O, —C(R3)(R4)O—, 
—-C(R3)(R4)N(C(O)R5)—, —CH(CO2R5)—, 
—C(R3)(R4)NH— or —CH(NO2)—; wherein R3 and R4 are 
individually H, phenyl or (C1—C4)alkyl and R5 is 
(C6—C,0)aryl or (C1—C4)alkyl; comprising reacting (a) an 
iodoaryl compound of formula (1): 
Y (1) 
(Ar) 
I 
wherein Y is OH or C(R3)(R4)X, and X is OH, N02, CO2R5, 
NH2 or NHC(O)R5, wherein R5 is (C6—C10)aryl or 
(C1—C4)alkyl; AI is a substituted aryl or unsubstituted aryl 
moiety, and Y and I are positioned adjacent to each other on 
Ar; with (b) an internal alkyne of the formula R1CL‘CR2, in 
the presence of an effective amount of a Pd catalyst, a base 
and a chloride ion source, in an organic solvent, to yield said 
compound of the formula (2). 
2. The process of claim 1 wherein Y is OH. 
3. The process of claim 1 wherein Y is CH2X or 
C(CH3)2X. 
4. The process of claim 3 wherein X is OH. 
5. The process of claim 3 wherein X is NH2 or 
NHC(O)R5. . 
6. The process of claim 3 wherein X is CO2R5. 
7. The process of claim 1 wherein the palladium catalyst 
is a Pd(II) compound. 
8. The process of claim 7 wherein the Pd(II) catalyst is 
Pd(OAc)2. 
9. The process of claim 1 wherein the base is an alkali 
metal acetate or carbonate. 
10. The process of claim 1 wherein the reaction is carried 
out at about 50°—150° C. for about 8-48 hrs. 
11. The process of claim 1 wherein the reaction is carried 
out in dimethylformarnide or acetonitrile. 
12. The process of claim 1 wherein the molar ratio of the 
compound (1) to the alkyne is about 1:1.1—10. 
13. The process of claim 1 wherein the chloride ion source 
is LiCl. 
14. The process of claim 1 wherein the compound of 
formula 1 is 
R6 (3) 
wherein R6 and R7 are individually (C1—C4)alkyl, chloro, 
bromo, hydroxy, phenyl, (C1—C4)alkoxy, 
(C1—C4)a1kyl(C=O), (C1—C4)a1koxycarbonyl or together 
are benzo or methylenedioxy; and the compound of formula 
(2) is 
5,596,100 
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17. The process of claim 14 wherein R6 is H. 
R6 Z 18. The process of claim 17 wherein R7 is (C1—C4)alkyl, 
(C1—C4)alk0xy or (C1—C4)alkylC(O). 
/ R1- 5 19. The process of claim 14 wherein R1 and R2 are 
individually (C1—C4)alkyl, phenyl, Si((C1—C4)alkyl)3 or 
R7 R2 C02((C1—C4)a11<y1) 
15_ The process of Claim 14 Whgrein Y is OH 20. The process of claim 14 wherein R6 and R7 are H. 
16. The process of claim 14 wherein R3, R4 and R5 are 
(C1—C4)alkyl. * * >l< >|< >|< 
